ABOUT WANHAI

Wanhai Medical Instruments Co., Ltd. is a leading solution provider and manufacturer of injection systems for self-medication located in Changzhou City Jiangsu Province China. With a plant area of 12000 square meters, Wanhai Medical's business covers more than 40 countries and regions, we are supplying our products and services to dozens of well-known pharmaceutical companies all over the world. Wanhai Medical is focusing on developing and manufacturing high-quality reusable and disposable(prefilled) pens and auto-injectors. Our injection devices are ideally designed for use with insulin, peptides, other hormone-based therapies, and monoclonal antibody therapy such as Human Growth Hormone (HGH), Glucagon-Like Peptide-1 (GLP-1, Liraglutide, Exenatide, Dulaglutide, Semaglutide)...

ISO

ISO

13485

ISO

CE

CERTIFICATION

十万级洁净车间

EXPORT TO MORE THAN 20 COUNTRIES

PRODUCES MILLIONS OF PENS ANNUALLY

GRASP KEY TECHNOLOGY

HOLDS A NUMBER OF PATENTS

SCOPE OF APPLICATION

+
  • INSULIN

    Recombinant Human Insulin, Insulin Aspart, Insulin Glargine, Insulin Degludec, Insulin Lispro, etc

  • MONOCLONAL ANTIBODY

    Widely used in the monoclonal antibody drugs that packed by prefilled syringe for the treatment of anti-tumor, chronic disease, autoimmune diseases.

  • POLYPEPTIDE

    Glucagon-Like Peptide-1 (GLP-1), i.e. Liraglutide, Exenatide, Dulaglutide, Semaglutide, etc.

  • OTHERS

    Growth Hormone (GH), Follicle-Stimulating Hormone (FSH) Parathyroid Hormone (PTH) , Etc.

WANHAI PRODUCTS

+
WH-RA4

WH-RA4

WH-RB1

WH-RB1

WH-DB1

WH-DB1

Wanhai Medical obtained CE Certification and ISO 13485 QMS Certificate for medical devices issued by TÜV SÜD, Class II Medical Device Registration Certificate issued by China Nation Medical Product Administration (NMPA). Wanhai Medical also holds dozens of key technology patents and a number of quality test reports from more than 30 third-party institutions.

NEWS CENTER

+